YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 55.50
+1.00 (1.83%)
Apr 2, 2026, 1:30 PM CST
YungShin Global Holding Revenue
In the year 2025, YungShin Global Holding had annual revenue of 8.38B TWD with 4.28% growth. YungShin Global Holding had revenue of 2.16B in the quarter ending December 31, 2025, with 0.18% growth.
Revenue
8.38B
Revenue Growth
+4.28%
P/S Ratio
1.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.38B | 343.95M | 4.28% |
| Dec 31, 2024 | 8.03B | 1.00B | 14.29% |
| Dec 31, 2023 | 7.03B | -283.83M | -3.88% |
| Dec 31, 2022 | 7.31B | -493.29M | -6.32% |
| Dec 31, 2021 | 7.81B | -279.61M | -3.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.25B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.19B |
| Formosa Laboratories | 4.85B |
| ScinoPharm Taiwan | 3.16B |
| Handa Pharmaceuticals | 1.73B |
| Center Laboratories | 1.52B |